{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:12:59Z","timestamp":1792872779529,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003852","name":"Regione Campania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.msard.2026.107348","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T15:51:30Z","timestamp":1782575490000},"page":"107348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Real-world analytical and clinical evaluation of the Siemens Atellica\u00ae immunoassay for plasma neurofilament light chain in multiple sclerosis"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0756-9877","authenticated-orcid":false,"given":"Valerio","family":"Nicolella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Criscuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Fiorenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Novarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Sorvillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Carotenuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Petracca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Lanzillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Castaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Brescia Morra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Moccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107348_bib0001","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1515\/cclm-2022-1181","article-title":"Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood","volume":"61","author":"Andreasson","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.msard.2026.107348_bib0002","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00415-023-12135-w","article-title":"Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing\u2013remitting multiple sclerosis: a 20-year follow-up cohort","volume":"271","author":"Arroyo Pereiro","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107348_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2024.119817","article-title":"Head-to-head comparison of four plasma neurofilament light chain (NfL) immunoassays","volume":"561","author":"Ashrafzadeh-Kian","year":"2024","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.msard.2026.107348_bib0004","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200427","article-title":"Exploring the clinical utility of neurofilament light chain assays in multiple sclerosis management","volume":"12","author":"Bar-Or","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107348_bib0005","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200052","article-title":"Serum GFAP and NfL levels differentiate subsequent progression and disease activity in patients with progressive multiple sclerosis","volume":"10","author":"Barro","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107348_bib0006","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(22)00009-6","article-title":"Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study","volume":"21","author":"Benkert","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107348_bib0007","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jn\/nxab381","article-title":"BMI and allostatic load are directly associated with longitudinal increase in plasma neurofilament light among urban middle-aged adults","volume":"152","author":"Beydoun","year":"2022","journal-title":"J. Nutr."},{"key":"10.1016\/j.msard.2026.107348_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120447","article-title":"Validation and generation of age-specific reference intervals for a new blood neurofilament light chain assay","volume":"577","author":"Booth","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.msard.2026.107348_bib0009","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1515\/cclm-2025-1476","article-title":"Comparative analysis of three platforms for serum NfL quantification in healthy controls and MS patients","volume":"64","author":"Dargvainiene","year":"2026","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.msard.2026.107348_bib0010","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.26446","article-title":"Contributors to serum <scp>NfL<\/scp>levels in people without neurologic disease","volume":"92","author":"Fitzgerald","year":"2022","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2026.107348_bib0011","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/jnnp-2025-336513","article-title":"Moderate\u2013high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis","volume":"97","author":"Foong","year":"2026","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107348_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.104970","article-title":"Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management","volume":"101","author":"Freedman","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.msard.2026.107348_bib0013","doi-asserted-by":"crossref","DOI":"10.1515\/cclm-2025-1743","article-title":"Translating neurofilament light chain testing into clinical practice: a multidisciplinary implementation roadmap","author":"Furlan","year":"2026","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"10.1016\/j.msard.2026.107348_bib0014","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1177\/13524585221122916","article-title":"Serum neurofilament light chain predicts cognitive worsening in secondary progressive multiple sclerosis better than brain MRI measures","volume":"28","author":"Gaetani","year":"2022","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2026.107348_bib0015","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jamaneurol.2023.2125","article-title":"Initiation patterns of disease-modifying therapies for multiple sclerosis among US adults and children, 2001 through 2020","volume":"80","author":"Henderson","year":"2023","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2026.107348_bib0016","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1093\/brain\/awv258","article-title":"Defining reliable disability outcomes in multiple sclerosis","volume":"138","author":"Kalincik","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107348_bib0017","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.msard.2026.107348_bib0018","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41582-024-00955-x","article-title":"Neurofilaments as biomarkers in neurological disorders \u2014 towards clinical application","volume":"20","author":"Khalil","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2026.107348_bib0019","doi-asserted-by":"crossref","first-page":"E1007","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107348_bib0020","doi-asserted-by":"crossref","DOI":"10.1177\/11772719251364018","article-title":"Advancing clinical use of neurofilament light chain: translational insights from research to routine practice","volume":"20","author":"La Civita","year":"2025","journal-title":"Biomark. Insight"},{"key":"10.1016\/j.msard.2026.107348_bib0021","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1177\/13524585231205973","article-title":"Worsening MS-A reappraisal of how we characterize the MS disease course","volume":"29","author":"Lublin","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107348_bib0022","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107348_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123115","article-title":"Clinical utility of the Lumipulse\u2122 immunoassay for plasma neurofilament light chain in multiple sclerosis","volume":"463","author":"Nicolella","year":"2024","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107348_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1620468","article-title":"Investigating the contribution of laboratory parameters on plasma neurofilament light chain levels in multiple sclerosis","volume":"16","author":"Nicolella","year":"2025","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107348_bib0025","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-13223-9","article-title":"Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis","volume":"272","author":"Nicolella","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107348_bib0026","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/13524585241311154","article-title":"Forever young","volume":"31","author":"Sastre-Garriga","year":"2025","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2026.107348_bib0027","doi-asserted-by":"crossref","unstructured":"Sheth U., Harrison R., Ferber K., Rosenbaugh E.G., Bevis A., Khillan R., et al. Measuring neurofilament light in human plasma and cerebrospinal fluid: a comparison of five analytical immunoassays 2025. https:\/\/doi.org\/10.1101\/2025.05.05.652212.","DOI":"10.1101\/2025.05.05.652212"},{"key":"10.1016\/j.msard.2026.107348_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac174","article-title":"Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years","volume":"4","author":"Simren","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.msard.2026.107348_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.106166","article-title":"Neurofilament light in serum: reference values and effect of risk factors for multiple sclerosis","volume":"92","author":"S\u00f8ndergaard","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107348_bib0030","doi-asserted-by":"crossref","first-page":"E2448","DOI":"10.1212\/WNL.0000000000207957","article-title":"Agreement between published reference resources for neurofilament light chain levels in people with Multiple sclerosis","volume":"101","author":"Sotirchos","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107348_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.654942","article-title":"Serum neurofilament light chain measurement in MS: hurdles to clinical translation","volume":"15","author":"Thebault","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.msard.2026.107348_bib0032","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1177\/13524585241277044","article-title":"Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic","volume":"30","author":"van Lierop","year":"2024","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2026.107348_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105412","article-title":"Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA\u2122, Ella\u2122, and Lumipulse\u2122 in multiple sclerosis na\u00efve patients","volume":"82","author":"Vecchio","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107348_bib0034","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/acn3.51676","article-title":"Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface","volume":"9","author":"Vermunt","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2026.107348_bib0035","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1093\/brain\/awaf331","article-title":"Combined magnetic resonance imaging and serum analysis reveals distinct multiple sclerosis types","volume":"148","author":"Willard","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107348_bib0036","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1177\/13524585221114441","article-title":"Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: analysis from the MS-STAT randomised controlled trial","volume":"28","author":"Williams","year":"2022","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2026.107348_bib0037","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1177\/13524585251389797","article-title":"Clinical validation of a novel in vitro diagnostic neurofilament light chain assay for the prognostication of disease activity in people with relapsing multiple sclerosis","volume":"31","author":"Ziemssen","year":"2025","journal-title":"Mult. Scler. J."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:36:19Z","timestamp":1786023379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826003846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"alternative-id":["S2211034826003846"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107348","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world analytical and clinical evaluation of the Siemens Atellica\u00ae immunoassay for plasma neurofilament light chain in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107348"}}